key: cord-0859576-04i9yyk1
authors: Zhu, Yue; Scholle, Frank; Kisthardt, Samantha C.; Xie, De-Yu
title: Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E
date: 2022-04-12
journal: Virology
DOI: 10.1016/j.virol.2022.04.005
sha: 4098c18ae289dcee3b8099cf327dfcc0d4db5a5e
doc_id: 859576
cord_uid: 04i9yyk1

Since December 2019, the deadly novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the current COVID-19 pandemic. To date, vaccines are available in the developed countries to prevent the infection of this virus; however, medicines are necessary to help control COVID-19. Human coronavirus 229E (HCoV-229E) causes the common cold. The main protease (M(pro)) is an essential enzyme required for the multiplication of these two viruses in the host cells, and thus is an appropriate candidate to screen potential medicinal compounds. Flavonols and dihydroflavonols are two groups of plant flavonoids. In this study, we report docking simulation with two M(pro) enzymes and five flavonols and three dihydroflavonols, in vitro inhibition of the SARS-CoV-2 M(pro), and in vitro inhibition of the HCoV 229E replication. The docking simulation results predicted that (+)-dihydrokaempferol, (+)- dihydroquercetin, (+)-dihydromyricetin, kaempferol, quercetin, myricentin, isoquercitrin, and rutin could bind to at least two subsites (S1, S1’, S2, and S4) in the binding pocket and inhibit the activity of SARS-CoV-2 M(pro). Their affinity scores ranged from −8.8 to −7.4 (kcal/mol). Likewise, these compounds were predicted to bind and inhibit the HCoV-229E M(pro) activity with affinity scores ranging from −7.1 to −7.8 (kcal/mol). In vitro inhibition assays showed that seven available compounds effectively inhibited the SARS-CoV-2 M(pro) activity and their IC(50) values ranged from 0.125 to 12.9 μM. Five compounds inhibited the replication of HCoV-229E in Huh-7 cells. These findings indicate that these antioxidative flavonols and dihydroflavonols are promising candidates for curbing the two viruses.

SARS-CoV-2 is the abbreviation of the novel severe acute respiratory syndrome coronavirus 2. One-way analysis of variance (ANOVA) was performed to evaluate the statistical significance.

The P-value less than 0.05 means significant differences. structure is featured with a substrate-binding pocket (Fig. 3a) . When the 3D structure of the protein was downloaded from the public database, the peptide inhibitor N3 was shown to bind to this 259 pocket. During protein preparation, N3 was removed for docking. The simulation results showed 260 that (+)-DHQ, (+)-DHK, (+)-DHM, quercetin, kaempferol, myricetin, isoquercitrin, rutin, (-)-261 epicatechin, (+)-catechin, and ebselen bound to the binding pocket (Fig. 3b-c) . The resulting 262 affinity scores for (+)-DHQ, (+)-DHK, (+)-DHM, quercetin, kaempferol, myricetin, isoquercitrin, 263 and rutin ranged from -8.8 to -7.4 (kcal/mol), lower and better than the score of ebselen (-6.6) 264 (Table 1 ). The scores among the aglycones of (-)-epicatechin, (+)-catechin, three dihydroflavonols, 265 and three flavonol aglycones were close, either -7.4 or -7.5 (kcal/mol). These data suggested that 266 dihydroflavonols, flavonols, and glycosylated flavonols could potentially inhibit the M pro activity. As we reported recently (Zhu and Xie, 2020), the M pro substrate-binding pocket includes four 270 subsites, S1', S1, S2, and S4 (Fig. 3a ). Cys145 is a critical residue located at the space among 271 subsites S1, S1', and S2 ( recently (Zhu and Xie, 2020), it bound to this residue featured by three rings facing to the S1 and 276 S1' subsites (Fig. 4b) . The docking simulation results showed that three dihydroflavonols, three 277 flavonol aglycones, and two glycosylated flavonols bound to 2 to 4 subsites via the Cys145 residue.

In three dihydroflavonols tested, (+)-DHK and (+)-DHQ showed a difference in their occupation 279 in the binding site. The A and B rings of (+)-DHK and (+)-DHQ dwelled in the S1' and S2 subsites 280 and their heterocycle C ring resided in the space between the S1 and S2 subsites ( Fig. 4c-d) . The A and B rings of DHM occupied the S1 and S4 subsites and the heterocycle C ring resided in the 282 space between the S1 and S2 subsites (Fig. 4e) . In three flavonol aglycones tested, the occupation 283 of kaempferol was different from that of quercetin and myricetin. The A-ring, B-ring, and 284 heterocycle C-ring of kaempferol resided in the S1', S2, and the space between S1 and S2, 285 respectively (Fig. 4f) . The A-ring, B-ring, and the heterocycle C-ring of quercetin and myricetin 286 dwelled in the S1, S4, and the space between S1 and S2 ( Fig. 4g-h) . These simulation results glucose of isoquercitrin occupied the S2, S1', the space between S1 and S2, and S1 (Fig. 2i ). The

A-ring, B-ring, heterocycle C-ring, 6-β-glucopyranose, and 1-L-α-rhamnopyranose of rutin 292 occupied S4, S1', the space between S1/S2, S1, and S4 (Fig. 4j ). The features of the binding of 293 rutin to these subsites were similar to those characterized by a previous virtual study (Xu et to inhibit the M pro activity via delivering a compound to the Cys145 residue at the space across the 354 region of S1' and S1 subsites (Dai et al., 2020). Ebselen is a small molecule candidate that has 355 been found to inhibit the M pro activity with an IC50 0.46 µM (Jin et al., 2020). Its structure featured 356 with three rings was revealed to be an effective vessel to deliver its carbonyl group to the CYS145 357 residue (Fig. 4b) . We recently reported another strategy. We have found that epicatechin gallate, flavan-3-ol gallates, the structures of these two groups might have a potential to reside in the spaces 368 of S1 and S2 subsites. In the present study, our ligand-docking simulation showed that these two 369 groups of compounds could bind to the substrate-binding pocket of M pro and occupied their 370 heterocyclic C ring in the crossing region between S1 and S2. Furthermore, the docking results 371 predicted the A-ring and B-ring of two, three, two, and one compounds could bind to S1' and S2, 372 S1 and S4, S2 and S1', and S4 and S1', respectively (Fig. 4) . The docking results further showed that a glycosylation of quercetin increased the dwelling capacity in the binding site. Quercetin was 374 predicted to dwell at S1, S4, and the space between S1 and S2. Isoquercitrin results from the 375 glycosylation of quercetin at 3-OH. The docking simulation predicted that the A-ring, B-ring, C-376 ring, and glucosyl group of isoquercitrin occupied S2, S1', the space between S1 and S2, and S1, 377 respectively. Rutin derives from the glycosylation of quercetin at 3-OH by a disaccharide rutinose 378 (α-L-rhamnopyranosyl-(1→6 (-β-D-glucopyranose). The docking simulation predicted that the A-379 ring, B-ring, C-ring, glucosyl group, and rhamnosyl group dwelled at S4, S1', the space between 380 S1 and S2, S1, and S4, respectively (Fig. 4 j) . The increase of binding subsites was reflected by Given that SARS-CoV-2 can be only handled in the BSL-3 laboratories, we cannot access this 393 deadly virus to test the effects of these compounds on its replication in host cells. Instead, we 394 selected the less pathogenic HCoV-229E to test the inhibitory activity of these compounds. We Table 1 ). Based on these data, we could test five compounds with HCoV-229E. In tested 405 concentrations, DHQ and isoquercitrin starting from 2.5 µM showed a significant inhibition of 406 HCoV-229E replication in Huh-7 cells. Quercetin could slightly reduce the replication of HCoV-407 229E at 2.5 µM and significantly inhibited the replication of this virus at higher concentrations 408 (Fig. 8a) . These positive results not only supported the docking simulation results that these 409 compounds bound to the M pro of HCoV-229E (Table 1) , but also substantiated the results of in 410 vitro assays that these compounds effectively inhibited the SARS-CoV-2 M pro activity (Fig. 7) . 411 We previously demonstrated that EGCG could effectively inhibit the activity of the SARS-CoV-2 412 M pro (Zhu and Xie, 2020). Herein, we used it as a positive control. The resulting data showed that HCoV-229E (Fig. 8 a) , which was supported by the results of the docking simulation and its affinity score (Fig. 6 and Table 1 ). Accordingly, this datum indicates the difference between 420 HCoV-229E and SARS-CoV-2. Taken together, these data indicate that HCoV-229E is 421 appropriate substitute to screen inhibitors of SARS-CoV-2 by targeting the M pro of these two 

Demographic 704 Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program

Bioassay-guided isolation 707 of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis 708 leaves

Modulation of chronic inflammation by quercetin: The beneficial effects on obesity

Role of Quercetin in Sports Nutrition

Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, 736 double-blinded, placebo-controlled, cross-over trial

Suppression of hepatitis-B virus expression 738 and replication by hepatitis-C virus core protein in Huh-7 cells

Clinical isolates of human coronavirus 229E bypass the 740 endosome for cell entry

Differences 742 in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-743 2008 depend on the S1 region sequence of the spike protein

Consumption of Quercetin and Quercetin-Containing Apple and Cherry Extracts Affects Blood Glucose 746

Hepatic Metabolism, and Gene Expression Patterns in Obese C57BL/6J High Fat-Fed Mice

THe method of 'Right and Wrong Cases' ('Constant stiumuli') without Gauss's formulae

Quercetin 751 effects on exercise induced oxidative stress and inflammation

753 Protection by quercetin and quercetin 3-O-beta-glueuronide of peroxynitrite-induced antioxidant 754 consumption in human plasma low-density lipoprotein

Dihydroquercetin as a means of antioxidative defence in rats with tetrachloromethane 757 hepatitis

Coronavirus genomics and bioinformatics analysis

Network pharmacology 782 and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and 783 prevent COVID-19

Proanthocyanidin biosynthesis -still more questions than answers? 785

Molecular and biochemical analysis of two 787 cDNA clones encoding dihydroflavonol-4-reductase from Medicago truncatula

Dietary rutin promoted the growth, serum 789 antioxidant response and flesh collagen, free amino acids contents of grass carp

Discovery of potential flavonoid 792 nnhibitors against COVID-19 3CL proteinase based on virtual screening strategy

Structural basis for the recognition of SARS-CoV-2 by 795 full-length human ACE2

Design of wide-spectrum inhibitors 798 targeting coronavirus main proteases

Structural Basis for Inhibiting Porcine Epidemic 800

Diarrhea Virus Replication with the 3C-Like Protease Inhibitor GC376